Category: News Well
Content tagged to appear in the middle column of the home page
SI-Bone says a Medicare contractor reversed its non-coverage decision for the medical device company's iFuse sacroiliac fusion device.
Si-Bone said a Medicare administrative contractor, Palmetto GBA, reversed its non-coverage policy on the medical device company's iFuse spinal fusion device.
The decision opens coverage for the iFuse sacroiliac procedure to patients on a case-by-case basis in North Carolina, South Carolina, Virginia and West Virginia, according to a press release.
Orthopedics giant Stryker closes its previously announced acquisition of sports medicine company Pivot Medical.
Michigan orthopedics titan Stryker (NYSE:SYK) put a ribbon on its previously announced acquisition of Pivot Medical, closing the books on a deal that was pretty closed to begin with.
Irish medtech maker Mainstay Medical initiates an Australian clinical trial of its ReActiv8 neurostimulation implant in treatment of chronic low back pain.
Dublin-based Mainstay Medical touted the launch of a new clinical trial evaluating its ReActiv8 implantable neurostimulator at 3 clinical sites in Australia.
Biotherapeutics maker Vital Therapies raises $14 million in an equity financing round ahead of its revived initial public offering.
Bio-artificial liver maker Vital Therapies is prepared to take another run at its initial public offering, months after deciding to put off the IPO to await more favorable market conditions.
The California biotech company filed updated registration statements signaling its intent to launch the IPO, wiping clean the pricing set in November 2013. The new offering cap and per-share pricing have yet to be announced.
A federal appeals court applies the U.S. Supreme Court's decision in a lawsuit between Medtronic and Boston Scientific over pacemaker patents, remanding the case back to a lower court for an invalidity decision.
Shares of Cantel Medical come under pressure despite strong fiscal 2nd-quarter results that beat expectations on Wall Street.
Cantel Medical (NYSE:CMN) shares are down nearly 4% this morning after the medical device company reported its fiscal 2nd-quarter results.
Patient Safety Technologies agrees to make additional disclosures to settle shareholder lawsuits filed over its impending $120 million buyout by Stryker Corp.